abstract |
The present invention provides compounds of formula (I), or a stereoisomer or pharmaceutically acceptable salt thereof, wherein all variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors, which are useful as pharmaceuticals. |